Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback